{
  "id": "cidp",
  "title": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
  "version": "1.0",
  "icd10": [
    "** G61.81 (Chronic inflammatory demyelinating polyneuritis)",
    "G61.89 (Other inflammatory polyneuropathies)",
    "G61.9 (Inflammatory polyneuropathy",
    "unspecified)"
  ],
  "scope": "** Diagnosis and management of typical CIDP and CIDP variants in adults. Covers diagnostic criteria (EFNS/PNS), electrodiagnostic findings, immunotherapy options, and monitoring. Excludes acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome), hereditary demyelinating neuropathies (CMT), and purely axonal chronic neuropathies.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline, exclude hematologic disease",
          "target": "Normal"
        },
        {
          "item": "CMP",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Renal/hepatic function, glucose",
          "target": "Normal"
        },
        {
          "item": "HbA1c",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Diabetes-associated neuropathy",
          "target": "<6.5%"
        },
        {
          "item": "TSH",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Thyroid dysfunction",
          "target": "Normal"
        },
        {
          "item": "Vitamin B12",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency neuropathy",
          "target": ">400 pg/mL"
        },
        {
          "item": "Serum protein electrophoresis (SPEP)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Monoclonal gammopathy (MGUS, myeloma)",
          "target": "No M-spike"
        },
        {
          "item": "Immunofixation (serum)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Paraprotein identification",
          "target": "Negative"
        },
        {
          "item": "Free light chains (serum)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Light chain disease",
          "target": "Normal ratio"
        }
      ],
      "Extended Workup": [
        {
          "item": "HIV",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "HIV-associated neuropathy",
          "target": "Negative"
        },
        {
          "item": "Hepatitis B/C",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Before immunotherapy; hepatitis-associated neuropathy",
          "target": "Negative"
        },
        {
          "item": "ANA",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Connective tissue disease",
          "target": "Negative"
        },
        {
          "item": "Anti-MAG antibody",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "MAG-associated neuropathy (DADS variant)",
          "target": "Negative"
        },
        {
          "item": "Anti-GM1, anti-GD1a antibodies",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "MMN, GBS variants",
          "target": "Negative"
        },
        {
          "item": "Anti-ganglioside panel",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Immune-mediated neuropathies",
          "target": "Negative"
        },
        {
          "item": "Urine protein electrophoresis (UPEP)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Multiple myeloma, POEMS",
          "target": "Negative"
        },
        {
          "item": "VEGF level",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "POEMS syndrome if suspected",
          "target": "Normal"
        },
        {
          "item": "IgG/IgA/IgM levels",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Before IVIG; IgA deficiency screening",
          "target": "Normal; document IgA level"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Anti-NF155, anti-CNTN1, anti-Caspr1 antibodies",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Nodal/paranodal antibody-associated CIDP",
          "target": "Negative"
        },
        {
          "item": "Genetic testing (PMP22, MPZ, GJB1)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If hereditary neuropathy suspected (CMT)",
          "target": "Negative"
        },
        {
          "item": "Bone marrow biopsy",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If POEMS or myeloma suspected",
          "target": "Normal"
        },
        {
          "item": "Fat pad biopsy",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Amyloidosis",
          "target": "Negative"
        }
      ],
      "Lumbar Puncture": [
        {
          "item": "Opening pressure",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "rationale": "Baseline",
          "target": "Normal"
        },
        {
          "item": "Cell count (tubes 1 and 4)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "rationale": "Exclude infection, malignancy",
          "target": "WBC <10/mm³ (albuminocytologic dissociation)"
        },
        {
          "item": "Protein",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "rationale": "Typically elevated in CIDP",
          "target": "Often >45-100 mg/dL"
        },
        {
          "item": "Glucose",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "rationale": "Infection",
          "target": "Normal"
        },
        {
          "item": "Cytology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "rationale": "Carcinomatous meningitis",
          "target": "Negative"
        },
        {
          "item": "Oligoclonal bands",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "rationale": "MS, other inflammatory",
          "target": "Usually negative in CIDP"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "Nerve conduction studies (NCS)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At diagnosis",
          "target": "Demyelinating features (see criteria)",
          "contraindications": "Anticoagulation (for needle EMG)"
        },
        {
          "item": "Electromyography (EMG)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At diagnosis",
          "target": "Secondary axonal changes; denervation",
          "contraindications": "Same"
        },
        {
          "item": "MRI spine with contrast (cervical/lumbar)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At diagnosis",
          "target": "Nerve root enlargement/enhancement",
          "contraindications": "Contrast allergy, renal disease"
        }
      ],
      "Extended": [
        {
          "item": "MRI brachial/lumbosacral plexus",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If plexopathy suspected",
          "target": "Plexus enlargement/enhancement",
          "contraindications": "Per MRI"
        },
        {
          "item": "Nerve ultrasound",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Emerging modality",
          "target": "Nerve enlargement (CSA increase)",
          "contraindications": "None"
        },
        {
          "item": "PET-CT",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "POEMS, lymphoma, malignancy workup",
          "target": "Sclerotic lesions, lymphadenopathy",
          "contraindications": "Per PET"
        },
        {
          "item": "Nerve biopsy (sural)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Diagnostic uncertainty; vasculitis suspected",
          "target": "Demyelination, inflammation",
          "contraindications": "Rarely needed"
        }
      ]
    },
    "Treatment": {
      "First-Line Immunotherapy": [
        {
          "item": "IVIG (Intravenous Immunoglobulin)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 g/kg",
                "orderSentence": "IVIG (Intravenous Immunoglobulin) 2 g/kg PO"
              }
            ],
            "route": "PO",
            "instructions": "Induction: 2 g/kg divided over 2-5 days; Maintenance: 0.4-1 g/kg q3-4 weeks (adjust based on response)",
            "orderSentence": "IVIG (Intravenous Immunoglobulin) 2 g/kg PO"
          },
          "contraindications": "IgA deficiency (use IgA-depleted product), renal failure, thrombosis history",
          "monitoring": "Renal function, headache, aseptic meningitis, thrombosis",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "SCIG (Subcutaneous Immunoglobulin)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "instructions": "Convert from IVIG at equivalent weekly dose (total monthly IVIG dose ÷ 4); administer weekly",
            "orderSentence": "SCIG (Subcutaneous Immunoglobulin) - SC - see dosing"
          },
          "contraindications": "Same (fewer systemic reactions)",
          "monitoring": "Local site reactions",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Plasma exchange (PLEX)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "instructions": "5-7 exchanges over 2-3 weeks; 1-1.5 plasma volumes/exchange",
            "orderSentence": "Plasma exchange (PLEX) - - - see dosing"
          },
          "contraindications": "Hemodynamic instability, line access",
          "monitoring": "Hemodynamics, electrolytes (Ca, Mg), fibrinogen",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Corticosteroids",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "60-80 mg",
                "orderSentence": "Corticosteroids 60-80 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "Prednisone 60-80 mg daily or 1 mg/kg/day × 4-8 weeks, then slow taper over 6-12 months; OR pulsed methylprednisolone 1000 mg IV × 3 days monthly",
            "orderSentence": "Corticosteroids 60-80 mg IV"
          },
          "contraindications": "Uncontrolled DM, active infection, osteoporosis (relative)",
          "monitoring": "Glucose, BP, bone density, weight, infection",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Second-Line / Steroid-Sparing Agents": [
        {
          "item": "Azathioprine",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg",
                "orderSentence": "Azathioprine 50 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 50 mg daily; increase by 50 mg q2 weeks to 2-3 mg/kg/day",
            "orderSentence": "Azathioprine 50 mg PO"
          },
          "contraindications": "TPMT deficiency (check before starting), pregnancy",
          "monitoring": "CBC, LFTs, TPMT level",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Mycophenolate mofetil",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg",
                "orderSentence": "Mycophenolate mofetil 500 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID",
            "orderSentence": "Mycophenolate mofetil 500 mg PO"
          },
          "contraindications": "Pregnancy, severe GI disease",
          "monitoring": "CBC, LFTs",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rituximab",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "375 mg",
                "orderSentence": "Rituximab 375 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "375 mg/m² IV weekly × 4 OR 1000 mg IV × 2 doses (days 1 and 15); repeat q6 months PRN",
            "orderSentence": "Rituximab 375 mg IV"
          },
          "contraindications": "Active infection, hepatitis B (screen)",
          "monitoring": "Infusion reactions, infection, B-cell counts",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cyclophosphamide",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "500-1000 mg",
                "orderSentence": "Cyclophosphamide 500-1000 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "Pulse: 500-1000 mg/m² IV monthly × 6; rarely used due to toxicity",
            "orderSentence": "Cyclophosphamide 500-1000 mg IV"
          },
          "contraindications": "Severe cytopenias, active infection",
          "monitoring": "CBC, renal function, bladder toxicity",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Cyclosporine",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "3-5 mg/kg",
                "orderSentence": "Cyclosporine 3-5 mg/kg PO"
              }
            ],
            "route": "PO",
            "instructions": "3-5 mg/kg/day in 2 divided doses; target trough 100-200 ng/mL",
            "orderSentence": "Cyclosporine 3-5 mg/kg PO"
          },
          "contraindications": "Renal impairment, uncontrolled HTN",
          "monitoring": "Renal function, BP, drug levels",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ],
      "Anti-Nodal Antibody-Positive CIDP (Special Population)": [
        {
          "item": "Rituximab (first-line for anti-nodal CIDP)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "375 mg",
                "orderSentence": "Rituximab (first-line for anti-nodal CIDP) 375 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "375 mg/m² weekly × 4 OR 1000 mg × 2 doses",
            "orderSentence": "Rituximab (first-line for anti-nodal CIDP) 375 mg PO"
          },
          "contraindications": "Per above",
          "monitoring": "Poor response to IVIG expected; rituximab preferred",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptomatic Treatment": [
        {
          "item": "Gabapentin (neuropathic pain)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "100-300 mg",
                "orderSentence": "Gabapentin (neuropathic pain) 100-300 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 100-300 mg TID; titrate to 900-3600 mg/day",
            "orderSentence": "Gabapentin (neuropathic pain) 100-300 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Renal impairment (adjust)",
          "monitoring": "Sedation, dizziness",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pregabalin (neuropathic pain)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "75 mg",
                "orderSentence": "Pregabalin (neuropathic pain) 75 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 75 mg BID; titrate to 150-300 mg BID",
            "orderSentence": "Pregabalin (neuropathic pain) 75 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Renal impairment (adjust)",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Duloxetine (neuropathic pain)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mg",
                "orderSentence": "Duloxetine (neuropathic pain) 30 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 30 mg daily; increase to 60 mg daily",
            "orderSentence": "Duloxetine (neuropathic pain) 30 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Severe hepatic/renal impairment, MAOIs",
          "monitoring": "Nausea, BP",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amitriptyline (neuropathic pain)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "10-25 mg",
                "orderSentence": "Amitriptyline (neuropathic pain) 10-25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 10-25 mg QHS; titrate to 50-100 mg QHS",
            "orderSentence": "Amitriptyline (neuropathic pain) 10-25 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Cardiac arrhythmia, glaucoma",
          "monitoring": "QTc, anticholinergic effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neuromuscular specialist",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "All patients; diagnosis confirmation and management"
        },
        {
          "item": "Physical therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Strengthening, gait training, fall prevention"
        },
        {
          "item": "Occupational therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "ADL assistance, adaptive equipment"
        },
        {
          "item": "Physiatry/PM&R",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Comprehensive rehabilitation, orthotics"
        },
        {
          "item": "Hematology/Oncology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "If monoclonal gammopathy or POEMS"
        },
        {
          "item": "Infusion center",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "IVIG administration"
        },
        {
          "item": "Home health nursing",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "SCIG training"
        },
        {
          "item": "Pain management",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Refractory neuropathic pain"
        }
      ],
      "Patient Instructions": [
        {
          "item": "CIDP is a chronic condition requiring ongoing treatment; not curable but manageable",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "IVIG infusions will be needed regularly (typically monthly)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report any worsening weakness, numbness, or falls immediately",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do NOT stop immunotherapy abruptly without physician guidance",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Fall prevention: remove rugs, improve lighting, use assistive devices",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Vaccination guidelines: avoid live vaccines on immunosuppression; IVIG may interfere with vaccine response",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Keep all neurology follow-up appointments for monitoring",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "GBS Foundation and similar resources for support",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Regular exercise within tolerance",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Balance and fall prevention strategies",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Foot care (sensory loss increases injury risk)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid excessive alcohol",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Maintain healthy weight",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Guillain-Barré syndrome (GBS)",
      "features": "Acute onset (<4 weeks), monophasic, nadir within 4 weeks",
      "tests": "Timing; CIDP requires >8 weeks progression"
    },
    {
      "diagnosis": "Multifocal motor neuropathy (MMN)",
      "features": "Pure motor, asymmetric, conduction block, anti-GM1+",
      "tests": "Anti-GM1; no sensory involvement; does not respond to steroids"
    },
    {
      "diagnosis": "POEMS syndrome",
      "features": "Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes",
      "tests": "VEGF elevated; sclerotic bone lesions; lambda light chain"
    },
    {
      "diagnosis": "CMT (Charcot-Marie-Tooth)",
      "features": "Family history, foot deformities (pes cavus), slow progression since childhood",
      "tests": "Genetic testing; no CSF protein elevation"
    },
    {
      "diagnosis": "MAG-associated neuropathy",
      "features": "Distal, sensory predominant, IgM paraprotein, anti-MAG positive",
      "tests": "Anti-MAG antibody; IgM gammopathy"
    },
    {
      "diagnosis": "Diabetic lumbosacral radiculoplexus neuropathy",
      "features": "Diabetes, weight loss, severe pain, proximal > distal",
      "tests": "Clinical; self-limited course"
    },
    {
      "diagnosis": "Vasculitic neuropathy",
      "features": "Painful, asymmetric, mononeuritis multiplex pattern",
      "tests": "ESR/CRP elevated; nerve/muscle biopsy"
    },
    {
      "diagnosis": "Amyloidosis",
      "features": "Autonomic dysfunction, carpal tunnel, heart failure, neuropathy",
      "tests": "Fat pad/nerve biopsy; SPEP"
    },
    {
      "diagnosis": "Lymphoma/carcinomatous neuropathy",
      "features": "Weight loss, lymphadenopathy, progressive",
      "tests": "Imaging; CSF cytology"
    }
  ],
  "evidence": [
    {
      "recommendation": "EFNS/PNS Diagnostic Criteria",
      "evidenceLevel": "Class I",
      "source": "[Van den Bergh et al., Eur J Neurol 2021](https://pubmed.ncbi.nlm.nih.gov/34327760/)"
    },
    {
      "recommendation": "IVIG effective for CIDP",
      "evidenceLevel": "Class I, Level A",
      "source": "[ICE trial (Hughes et al., Lancet Neurol 2008)](https://pubmed.ncbi.nlm.nih.gov/18178525/); [Cochrane Reviews (Eftimov et al., 2013)](https://pubmed.ncbi.nlm.nih.gov/24379104/)"
    },
    {
      "recommendation": "SCIG non-inferior to IVIG",
      "evidenceLevel": "Class I, Level A",
      "source": "[PATH trial (van Schaik et al., Lancet Neurol 2018)](https://pubmed.ncbi.nlm.nih.gov/29122523/)"
    },
    {
      "recommendation": "Corticosteroids effective for CIDP",
      "evidenceLevel": "Class I, Level A",
      "source": "Cochrane Reviews"
    },
    {
      "recommendation": "Plasma exchange effective",
      "evidenceLevel": "Class I, Level A",
      "source": "Cochrane Reviews"
    },
    {
      "recommendation": "IVIG, steroids, PLEX equivalent efficacy",
      "evidenceLevel": "Class I",
      "source": "Multiple comparative studies"
    },
    {
      "recommendation": "Rituximab for anti-nodal CIDP",
      "evidenceLevel": "Class II, Level B",
      "source": "Case series; expert consensus"
    },
    {
      "recommendation": "Steroid-sparing agents",
      "evidenceLevel": "Class II-III, Level C",
      "source": "Limited controlled data"
    }
  ],
  "monitoring": [
    {
      "item": "MRC strength grading",
      "ED": "-",
      "HOSP": "Daily",
      "OPD": "Each visit",
      "ICU": "-",
      "frequency": "Each visit",
      "action": "Adjust immunotherapy"
    },
    {
      "item": "Functional scales (INCAT, ODSS)",
      "ED": "-",
      "HOSP": "Weekly",
      "OPD": "Each visit",
      "ICU": "-",
      "frequency": "q3 months",
      "action": "Adjust treatment"
    },
    {
      "item": "Grip strength (dynamometry)",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q3 months",
      "action": "Objective measure"
    },
    {
      "item": "NCS/EMG",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q6-12 months or with change",
      "action": "Treatment response"
    },
    {
      "item": "Renal function (IVIG patients)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Before each IVIG; q3 months",
      "action": "Hold/reduce IVIG if rising"
    },
    {
      "item": "IgG trough level",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q3-6 months",
      "action": "Adjust IVIG dose"
    },
    {
      "item": "Glucose (steroid patients)",
      "ED": "-",
      "HOSP": "Daily",
      "OPD": "Each visit",
      "ICU": "-",
      "frequency": "Per steroid use",
      "action": "Adjust DM meds"
    },
    {
      "item": "Bone density (steroid patients)",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "At baseline, q1-2 years",
      "action": "Calcium, vitamin D, bisphosphonate"
    },
    {
      "item": "CBC (immunosuppression)",
      "ED": "-",
      "HOSP": "Weekly",
      "OPD": "q3 months",
      "ICU": "-",
      "frequency": "Per agent",
      "action": "Adjust dose"
    },
    {
      "item": "Weight, BP (steroids)",
      "ED": "-",
      "HOSP": "Daily",
      "OPD": "Each visit",
      "ICU": "-",
      "frequency": "Per steroid use",
      "action": "Address"
    }
  ],
  "disposition": [
    {
      "disposition": "Outpatient management",
      "criteria": "Most patients; stable disease, able to ambulate, no respiratory concerns"
    },
    {
      "disposition": "Admit to hospital",
      "criteria": "New diagnosis requiring urgent workup, significant weakness (unable to walk), respiratory concerns, severe relapse"
    },
    {
      "disposition": "ICU admission",
      "criteria": "Respiratory failure (FVC <20 mL/kg, NIF <-30 cmH2O), hemodynamic instability"
    },
    {
      "disposition": "Discharge from hospital",
      "criteria": "Diagnosis established, treatment initiated, functionally stable, follow-up arranged"
    },
    {
      "disposition": "Long-term monitoring",
      "criteria": "Every 3-6 months with neuromuscular specialist; more frequent if unstable"
    }
  ]
}